Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice

被引:24
作者
Jaiswal, Abhishek [1 ]
Koley, Hemanta [1 ]
Mitra, Soma [1 ]
Saha, Dhira Rani [1 ]
Sarkar, Banwarilal [1 ]
机构
[1] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata 700010, India
关键词
Vibrio cholerae; Vibriophage; Phage cocktail; Lytic; Oral administration; BACTERIOPHAGE THERAPY; ESCHERICHIA-COLI; PHAGE THERAPY; COCKTAIL; EFFICACY; ANTIBIOTICS; RABBIT; TRIAL;
D O I
10.1016/j.ijmm.2014.02.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study, we have established an oral phage cocktail therapy in adult mice model and also performed a comparative analysis between phage cocktail, antibiotic and oral rehydration treatment for orally developed Vibrio cholerae infection. Four groups of mice were orally infected with Vibrio cholerae MAK 757 strain. Phage cocktail and antibiotic treated groups received 1 Chi 10(8) plaque forming unit/ml (once a daily) and 40 mg/kg (once a daily) as an oral dose respectively for consecutive three days after bacterial infection. In case of oral rehydration group, the solution was supplied after bacterial infection mixed with the drinking water. To evaluate the better and safer approach of treatment, tissue and serum samples were collected. Here, phage cocktail treated mice reduced the log(10) numbers of colony per gram by 3 logo (p < 0.05); however, ciprofloxacin treated mice reduced the viable numbers up to 5 log(10) (p < 0.05). Whereas, the oral rehydration solution application was not able to reduce the viable bacterial count but the disease progress was much more diminished (p > 0.05). Besides, it,was evident that antibiotic and phage cocktail treated group had a gradual decrease in both IL-6 and TNF-alpha,level for 3 days (p <0.05) but the scenario was totally opposite in bacterial control and oral hydration treated group. Histological examinations also endorsed the phage cocktail and ciprofloxacin treatment in mice. Although, in this murine model of cholera ciprofloxacin was found to be a better antimicrobial agent, but from the safety and specificity point of view, a better method of application could fill the bridge and advances the phages as a valuable agent in treating Vibrio cholerae infection. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:422 / 430
页数:9
相关论文
共 60 条
[1]   Bacteriophages φMR299-2 and φNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells [J].
Alemayehu, Debebe ;
Casey, Pat G. ;
McAuliffe, Olivia ;
Guinane, Caitriona M. ;
Martin, James G. ;
Shanahan, Fergus ;
Coffey, Aidan ;
Ross, R. Paul ;
Hill, Colin .
MBIO, 2012, 3 (02)
[2]  
[Anonymous], 1983, LANCET, V2, P1287
[3]  
[Anonymous], 2013, Wkly Epidemiol Rec, V88, P321
[4]  
[Anonymous], WHO DRUG INFORM
[5]  
[Anonymous], 2002, ICMR B, V4, P32
[6]   Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential [J].
Barrow, PA ;
Soothill, JS .
TRENDS IN MICROBIOLOGY, 1997, 5 (07) :268-271
[7]   DOUBLE-BLIND, RANDOMIZED, CONTROLLED CLINICAL-TRIAL OF NORFLOXACIN FOR CHOLERA [J].
BHATTACHARYA, SK ;
BHATTACHARYA, MK ;
DUTTA, P ;
DUTTA, D ;
DE, SP ;
SIKDAR, SN ;
MAITRA, A ;
DUTTA, A ;
PAL, SC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :939-940
[8]   Pathogenic potential of vibriophages against an experimental infection with Vibrio cholerae O1 in the RITARD model [J].
Bhowmick, Tushar Suvra ;
Koley, Hemanta ;
Das, Mayukh ;
Saha, Dhira Rani ;
Sarkar, B. L. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (06) :569-573
[9]   Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium [J].
Biswas, B ;
Adhya, S ;
Washart, P ;
Paul, B ;
Trostel, AN ;
Powell, B ;
Carlton, R ;
Merril, CR .
INFECTION AND IMMUNITY, 2002, 70 (01) :204-210
[10]   Phage therapy:: the Escherichia coli experience [J].
Brüssow, H .
MICROBIOLOGY-SGM, 2005, 151 :2133-2140